The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지
DOI QR코드

DOI QR Code

Overexpression of $AMPK{\alpha}1$ Ameliorates Fatty Liver in Hyperlipidemic Diabetic Rats

  • Seo, Eun-Hui (Department of Pharmacology, Medical Sciences Research Center, Dong-A University College of Medicine) ;
  • Park, Eun-Jin (Department of Pharmacology, Medical Sciences Research Center, Dong-A University College of Medicine) ;
  • Joe, Yeon-Soo (Department of Pharmacology, Medical Sciences Research Center, Dong-A University College of Medicine) ;
  • Kang, Soo-Jeong (Department of Pharmacology, Medical Sciences Research Center, Dong-A University College of Medicine) ;
  • Kim, Mi-Sun (Department of Pharmacology, Medical Sciences Research Center, Dong-A University College of Medicine) ;
  • Hong, Sook-Hee (Department of Pathology, Medical Sciences Research Center, Dong-A University College of Medicine) ;
  • Park, Mi-Kyoung (Department of Internal Medicine, Medical Sciences Research Center, Dong-A University College of Medicine) ;
  • Kim, Duk-Kyu (Department of Internal Medicine, Medical Sciences Research Center, Dong-A University College of Medicine) ;
  • Koh, Hyong-Jong (Department of Pharmacology, Medical Sciences Research Center, Dong-A University College of Medicine) ;
  • Lee, Hye-Jeong (Department of Pharmacology, Medical Sciences Research Center, Dong-A University College of Medicine)
  • Published : 2009.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

5'-AMP-activated protein kinase (AMPK) is a heterotrimeric complex consisting of a catalytic ($\alpha$) and two regulatory ($\beta$ and $\gamma$) subunits. Two isoforms are known for catalytic subunit (${\alpha}1$, ${\alpha}2$) and are encoded by different genes. To assess the metabolic effects of $AMPK{\alpha}1$, we examined the effects of overexpression of adenoviral-mediated $AMPK{\alpha}1$ in hyperlipidemic type 2 diabetic rats. The Otsuka Long-Evans Tokushima Fatty (OLETF) rat is an established animal model of type 2 diabetes that exhibits chronic and slowly progressive hyperglycemia and hyperlipidemia. Thirty five-week-old overt type 2 diabetic rats (n=10) were administered intravenously with Ad.$AMPK{\alpha}1$. AMPK activity was measured by phosphorylation of acetyl CoA carboxlyase (ACC). To investigate the changes of gene expression related glucose and lipid metabolism, quantitative real-time PCR was performed with liver tissues. Overexpression of $AMPK{\alpha}1$ showed that blood glucose concentration was decreased but that glucose tolerance was not completely recovered on 7th day after treatment. Plasma triglyceride concentration was decreased slightly, and hepatic triglyceride content was markedly reduced by decreasing expression of hepatic lipogenic genes. Overexpression of $AMPK{\alpha}1$ markedly improved hepatic steatosis and it may have effective role for improving hepatic lipid metabolism in hyperlipidemic state.

Keywords

References

  1. Asilmaz E, Cohen P, Miyazaki M, Dobrzyn P, Ueki K, Fayzikhodjaeva G, Soukas AA, Kahn CR, Ntambi JM, Socci ND, Friedman JM. Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J Clin Invest 113: 414-424, 2004
  2. Cohen P, Ntambi JM, Friedman JM. Stearoyl-CoA desaturase-1 and the metabolic syndrome. Curr Drug Targets Immune Endocr Metabol Disord 3: 271-280, 2003 https://doi.org/10.2174/1568008033340117
  3. Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-Aminoimidazole- 4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229: 558-565, 1995 https://doi.org/10.1111/j.1432-1033.1995.tb20498.x
  4. Crawford RM, Treharne KJ, Arnaud-Dabernat S, Daniel JY, Foretz M, Viollet B, Mehta A. Understanding the molecular basis of the interaction between NDPK-A and AMPK alpha 1. Mol Cell Biol 26: 5921-5931, 2006 https://doi.org/10.1128/MCB.00315-06
  5. Dobrzyn A, Ntambi JM. The role of stearoyl-CoA desaturase in body weight regulation. Trends Cardiovasc Med 14: 77-81, 2004 https://doi.org/10.1016/j.tcm.2003.12.005
  6. Foretz M, Ancellin N, Andreelli F, Saintillan Y, Grondin P, Kahn A, Thorens B, Vaulont S, Viollet B. Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes 54: 1331-1339, 2005 https://doi.org/10.2337/diabetes.54.5.1331
  7. Fryer LG, Parbu-Patel A, Carling D. Protein kinase inhibitors block the stimulation of the AMP-activated protein kinase by 5-amino- 4-imidazolecarboxamide riboside. FEBS Lett 531: 189-192, 2002 https://doi.org/10.1016/S0014-5793(02)03501-9
  8. Hardie DG. AMP-activated protein kinase: a master switch in glucose and lipid metabolism. Rev Endocr Metab Disord 5: 119-125, 2004 https://doi.org/10.1023/B:REMD.0000021433.63915.bb
  9. Hardie DG, Carling D. The AMP-activated protein kinase. Fuel gauge of the mammalian cell? Eur J Biochem 246: 259-273, 1997 https://doi.org/10.1111/j.1432-1033.1997.00259.x
  10. Hardie DG, Carling D, Carlson M. The amp-activated/snf1 protein kinase subfamily: Metabolic Sensors of the Eukaryotic Cell? Annu Rev Biochem 67: 821-855, 1998 https://doi.org/10.1146/annurev.biochem.67.1.821
  11. Hardie DG, Pan DA. Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans 30: 1064-1070, 2002 https://doi.org/10.1042/BST0301064
  12. Hardie DG, Scott JW, Pan DA, Hudson ER. M.anagement of cellular energy by the AMP-activated protein kinase system. FEBS Lett 546: 113-120, 2003 https://doi.org/10.1016/S0014-5793(03)00560-X
  13. Kawano K, Hirashima T, Mori S, Kurosumi M, Saitoh Y, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima fatty (OLETF) strain. Diabetes 41: 1422-1428, 1992 https://doi.org/10.2337/diabetes.41.11.1422
  14. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343, 2002 https://doi.org/10.1038/415339a
  15. Muoio DM, Seefeld K, Witters LA, Coleman RA. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that glycerol-3- phosphate acyltransferase is a novel target. Biochem J 338: 783-791, 1999 https://doi.org/10.1042/0264-6021:3380783
  16. Musi N, Hayashi T, Fujii N, Hirshman MF, Witters LA, Goodyear LJ. AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am J Physiol Endocrinol Metab 280: E677-E684, 2001
  17. Reiter AK, Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. Repression of protein synthesis and mTOR signaling in rat liver mediated by the AMPK activator aminoimidazole carboxamide ribonucleoside. Am J Physiol Endocrinol Metab 288: E980-E988, 2005
  18. Pencek RR, Shearer J, Camacho RC, James FD, Lacy DB, Fueger PT, Donahue EP, Snead W, Wasserman DH. 5-Aminoimidazole- 4-carboxamide-1-$\beta$-d-ribofuranoside causes acute hepatic insulin resistance in vivo. Diabetes 54: 355-360, 2005 https://doi.org/10.2337/diabetes.54.2.355
  19. Rutter GA, Xavier GDS, Leclerc I. Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J 375: 1-16, 2003 https://doi.org/10.1042/BJ20030048
  20. Saha AK, Avilucea PR, Ye JM, Assifi MM, Kraegen EW, Ruderman NB. Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. Biochem Biophys Res Commun 314: 580-585, 2004 https://doi.org/10.1016/j.bbrc.2003.12.120
  21. Thong FS, Graham TE. The putative roles of adenosine in insulin- and exercise-mediated regulation of glucose transport and glycogen metabolism in skeletal muscle. Can J Appl Physiol 27: 152-178, 2002 https://doi.org/10.1139/h02-011
  22. Winder WW, Hardie D. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 277: E1-10, 1999
  23. Winder WW, Wilson HA, Hardie DG, Rasmussen BB, Hutber CA, Call GB, Clayton RD, Conley LM, Yoon S, Zhou B. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase. A J Appl Physiol 82: 219-225, 1997 https://doi.org/10.1063/1.365801
  24. Wojtaszewski JF, Jorgensen SB, Hellsten Y, Hardie DG, Richter EA. Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 51: 284-292, 2002 https://doi.org/10.2337/diabetes.51.2.284
  25. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel F, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295, 2002 https://doi.org/10.1038/nm788
  26. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174, 2001

Cited by

  1. Actions and interactions of AMPK with insulin, the peroxisomal-proliferator activated receptors and sirtuins vol.7, pp.2, 2009, https://doi.org/10.1586/eem.12.9
  2. Treatment of nonalcoholic fatty liver disease: role of AMPK vol.311, pp.4, 2016, https://doi.org/10.1152/ajpendo.00225.2016
  3. Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance vol.426, pp.1, 2017, https://doi.org/10.1007/s11010-016-2878-8
  4. Astragaloside IV Inhibits Triglyceride Accumulation in Insulin-Resistant HepG2 Cells via AMPK-Induced SREBP-1c Phosphorylation vol.9, pp.None, 2009, https://doi.org/10.3389/fphar.2018.00345
  5. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice vol.18, pp.None, 2019, https://doi.org/10.1186/s12944-018-0955-6
  6. Palmitoylethanolamide counteracts hepatic metabolic inflexibility modulating mitochondrial function and efficiency in diet‐induced obese mice vol.34, pp.1, 2009, https://doi.org/10.1096/fj.201901510rr
  7. Activation of AMP-activated protein kinase signaling pathway ameliorates steatosis in laying hen hepatocytes vol.100, pp.3, 2009, https://doi.org/10.1016/j.psj.2020.10.059
  8. Dietary Micronutrient Management to Treat Mitochondrial Dysfunction in Diet-Induced Obese Mice vol.22, pp.6, 2009, https://doi.org/10.3390/ijms22062862
  9. Signal Transduction and Molecular Regulation in Fatty Liver Disease vol.35, pp.9, 2021, https://doi.org/10.1089/ars.2021.0076
  10. Serum- and glucocorticoid-induced kinase drives hepatic insulin resistance by directly inhibiting AMP-activated protein kinase vol.37, pp.1, 2009, https://doi.org/10.1016/j.celrep.2021.109785
  11. AMPK protects against alcohol-induced liver injury through UQCRC2 to up-regulate mitophagy vol.17, pp.11, 2009, https://doi.org/10.1080/15548627.2021.1886829